typhoid fever in 1840. Critical analysis of their works, however, does not support the contention that they discovered B. hominis.
Yakimoff (82, 83) has stated that the work of Brittan and Swayne included descriptions of B. hominis but Swayne's drawings of cholera bodies, in their clearest form, are Ascaris lumbricoides ova. Brittan provided drawings of "condensed air" of cholera patients (apparently a suspension of room dust in water condensed from the air) as well as feces from cholera patients and from healthy persons. He observed his annular bodies in all specimens except those from healthy persons. While his report of annular bodies in condensed air and specimens from cholera patients seems incredible, his drawings of diarrheic excretions show a few cells that might be B. hominis. The same drawings unmistakably depict A. lumbricoides and Trichuris trichiura ova. Thus, the credit given to Brittan and Swayne for the discovery of B. hominis is misplaced. Kean et al. (33) credited Fedor Aleksandrovich Losch, the discoverer of Entamoeba histolytica, with the discovery of B. hominis in 1849, but Losch's reports and illustrations do not corroborate this discovery (37, 38) . Because written descriptions may not be specific enough, more reliance must be placed on drawings. Losch's drawings are too indefinite to be identified as any specific ameba. Coupled with his extensive descriptions, they are of E. histolytica, but not B. hominis. From manuscripts that we have examined, Perroncito is more likely to have discovered B. hominis in 1899 (56) , but again there is insufficient documentation. Perroncito provided an adequate written description of B. hominis, but no drawings. He stated that the organism was probably a member of the coccidia. In the same year, Borini (5) , a worker in Perroncito's laboratory, referred to it as "a new Perroncito parasite," and called it a protozoan as well as "a corpuscle." No illustrations were provided. Borini, Perroncito's assistant, made no mention of a binomial in his publication later in 1899. Micheletti referred to Borini as "holding like opinions," but as we have seen, Borini provided no name, other than protozoan and corpuscle. In 1932, Micheletti (49) used the genus name provided by Alexieff (1), Blastocystis, added jalinus (origin unknown), and called the protozoan Blastocystis jalinus (Perroncito) . He stated that, by priority, the organism was B. jalinus Perroncito 1901 and not Blastocystis hominis Brumpt 1912 . This report is surrounded by mystery because Micheletti did not cite any 1901 publication by Perroncito , and no such publication has been uncovered to date. Perroncito apparently did not name the organism Coccidiumjalinum in 1899. Part of the answer to this quandary may lie in verbal communication, personal correspondence, or published material unavailable to us.
The first description fulfilling requirements of nomenclatural priority goes to Alexieff (1) for his 1911 description, naming the organism Blastocystis enterocola, a yeast. He applied the same binomial to cells that he observed in rats, guinea pigs, chickens, reptiles, and leeches. His appelation is prior to that of Brumpt, who in 1912 coined the name Blastocystis hominis (7) , changing the specific epithet from enterocola to hominis. The belief that Brumpt's classification had priority because he worked only with human material had an early influence, and the name B. hominis is now firmly entrenched and recognized worldwide. Because of the possibility that the organism will be further reassigned within the protozoa, this is not a good time to change the name back to B. enterocola. Some early workers observed Blastocystis cells in many animals, including flies, snakes, rodents, and cockroaches (47) , but these observations have been largely ignored. In the early days of microscopy, the tendency to be fooled by artifacts, degraded cells, and normal cells of all description was widespread. Many degenerate tissue cells, vegetable cells, and yeast cells, as well as many artifacts, resemble B. hominis. Degenerated hepatocytes in liver have been mistaken for B. hominis, which is then cited as an invasive liver parasite. Rosenbusch (61) mistakenly attributed the disease blackhead in turkeys to B. hominis through such an error in diagnosis, and in the same way human hepatic pathology has been attributed mistakenly to B. hominis.
Isolation of B. hominis has been confirmed only in humans, monkeys, apes, pigs, and, perhaps, guinea pigs. It is likely that more than one Blastocystis species is involved. Alexieff was accused of creating his new genus by confusing pollen grains and helminth ova, such as A. lumbricoides, with a new organism. The accusation was also aimed at Brittan and Swayne, against whom it was more accurately made.
Eminent early workers, including Swellingrebel (71), Alexieff (1), Wenyon (77) , and Cicchitto (12) , thought that B. hominis was a degenerate or cyst form of the flagellates Trichomonas intestinalis and Chilomastix mesnili or of Endolimax nana. Their opinion was accepted by many other workers in the field, and peripherally in other disciplines, and continued in force into the middle of the 20th century. Brumpt's publication (7) (Table 1) . Continued research on culture, physiology, and ultrastructure (84, 87) strengthened the need for this change in classification.
B. hominis is difficult to classify and may eventually be placed in an individual niche within the protozoa, based on the unique diversity of its shapes and sizes, its unique physiology, and some of its reproductive modes. Shared RNA sequences with other eucaryotic cells (31) confirm that B. hominis is a protozoan and perhaps belongs in a group by itself. Since its reclassification in 1976, it has been placed with the family Sporozoa (94) . However, the findings of motility by pseudopodia as well as feeding pseudopodia, extracellular location in the host, lack of an apical complex, According to the classification schema of Levine et al. (36) , the 1985 classification and description of B. hominis are as follows: kingdom Protista, subkingdom Protozoa, phylum Sarcomastigophora, subphylum Sarcodina, superclass Rhizopoda, class Lobosea, subclass Gymnamoeba, order Amoebida, new suborder Blastocystina, genus Blastocystis, species hominis-"cells spherical and widely variable in size, can be amebiform in disease, limiting membrane only, no cyst form, may have glycocalyx (capsule), large membrane-bound central body for schizogony occupying large volume of cell but absent in amebiform cell, delineating a peripheral band of cytoplasm including most of the cell's organelles, multinucleate, cytochrome-free mitochondria always present, division usually by binary fission, also plasmotomy, endodyogony, and schizogony, slow feeding pseudopodia, rapid locomotion pseudopodia, pinocytotic feeding, mesomitotic, no flagella, intestinal parasite of higher primates" (89) . This classification seems to suffice for the present.
MORPHOLOGY Light Microscopy
For diagnostic work, bright-field optics are preferred, because bright field is more universally available. For research, examination by differential interference contrast optics (DIC) of wet mount live preparations is required (Fig.  1) . Built-in photographic capability of proven quality should be included. By Nomarski optics, B. hominis nuclei are visible and normally associated with the brightest organelles, the mitochondria, which form rosettes about the nuclei ( Fig.  2C and D) . The mitochondria are normally spherical, but may elongate rapidly.
In clinical samples, B. hominis is brightly refractile and of widely variable diameter (4 to 15 p.m) and contains visible mitochondria. The organelles are gathered as one, two, or four thickened opposed pods in the thin band of peripheral cytoplasm. These pods bulge the central body membrane inward. The outer membrane remains entire and glistening, with no protuberances. A distinct band of capsular material, or slime, may surround the cell (Fig. 1C) and is apparent because it forms a transparent circle of variable thickness delineated on the inside by the cell membrane and on the outside by bacteria, cells, and food debris in the fecal suspension. In wet mounts, B. hominis cells at the edge of the cover glass quickly deform from oxygen intrusion, collapse, and release cytoplasmic contents, finally leaving empty membranes, looking like burst balloons ( Fig. 2A) . The B. hominis cell is extremely plastic, passing through constricted passages in its environment much like an erythrocyte. The mitochondria are stained selectively with Janus green and even better with the fluorescent dye rhodamine 123 (90) .
In cells from most clinical samples, the central body (CB), once called the vacuole, appears completely empty. It occupies a variable volume of the cell, from 50 to 95%, with average displacement of about 80%. It is always concentric with the outer membrane, never eccentric. The CB contents appear dense and stain as amorphous material or particles with Gram, Feulgen, trichrome, and hematoxylin-eosin stains, but by transmission electron microscopy (TEM) are seen to be membrane spheres of widely variant diameters. Trichrome stain may remain inside the CB, apparently trapped there, so that the CB appears uniformly dark.
In some infections the ameba form may be the only form seen, and diagnosis is difficult because it resembles leukocytes. The numbers of amebae, however, often exceed those of accompanying leukocytes. The cell outline is distinguishable from that of leukocytes. It is more diverse in morphology and appears stretched out along mucus strands because of its plasticity. Giemsa stain reveals well-defined and much larger nuclei in leukocytes, while the nuclei of the amebae are perfect spheres of 1-,m diameter, staining faintly. The ameba form is often seen in culture.
TEM
Fixation for electron microscopy is done anaerobically by adding 8% (vol/vol) glutaraldehyde with a pipette tip submerged directly in the growth sediment at the base of the egg slant culture (see section, "Culture"). This step initiates fixation and kills the B. hominis cells so that the compact growth sediment can be transferred to another tube of 4% glutaraldehyde in cacodylate buffer (72, 73) . After 1 h, the suspension is centrifuged at 500 x g for 10 min, decanted, resuspended in 1% glutaraldehyde buffer, and stored at 4°C. Dehydration and embedding are best done within 24 h of specimen collection but can be delayed when necessary.
The major forms of B. hominis are the CB form, the granular (mitochondrion) cell form, and the ameba form. A minor form is the uncommon schizont. In the gastrointestinal tract, the CB form predominates except in rampant infections, when the ameba form may be the only one seen or the two are seen together. Figure 3 illustrates some B. hominis forms seen by TEM.
CB form. As indicated, the granular form is so designated because of the high concentration of mitochondria in the cytoplasmic sphere, obscuring the CB. The CB form can be considered a B. hominis cell having a minimal number of mitochondria. Although the CB is commonly so large as to restrict the cytoplasm to a spherical band only 30 to 80 nm wide, in clinical material and cultures it is also seen as a diminished body remaining in the center of the cell. The cytoplasm then exceeds the CB in volume, and when the CB disappears, the total volume of the cell consists of cytoplasm plus organelles. The CB is directly involved with schizogony and becomes filled with progeny during this asexual reproductive mode. In developing to a schizont, the CB cell eventually loses the CB membrane, and its contents intermingle with the cytoplasm. There is evidence of passage of mitochondria and nuclei from cytoplasm to CB through the CB membrane or commingling after dissolution of the CB membrane. The complete role of the CB in schizogony and perhaps in other cell functions is complex and remains to be elucidated.
Ameba form. The ameba form of B. hominis provides the greatest challenge for diagnosis. In cultures, the ameba form reverts to the CB form whose morphologic characteristics and ability to undergo binary fission make it readily identifiable as B. hominis. In diarrheal fluid, however, the ameba form mimics leukocytes. An TEM is useful for examining the ameba form because the crescentic chromatin, or nucleolus ( Fig. 3B) , characteristic for B. hominis is well visualized. With experience, the ameba form is identifiable in wet mounts viewed by light or Nomarski optics. The ameba form, seen in diarrheal fluid of a patient who died of his disease (94) , was trapped in and between parallel mucus strains ( Fig. 4A and B) . Mucus exudate was an outstanding feature of this case; the patient had choleralike diarrhea of 3-month standing. Many B. hominis cells were elongated by mechanical stretching along the mucus strands. The large cells were ovoid and irregularly convoluted. One or two large pseudopods were present in some cells.
An ameba form cell from culture is seen in Fig. 2E . TEM shows that the cell surface is covered by a finely filamentous layer, 0.2 to 0.25 ,um thick. Pockets 90 nm in diameter are distributed at 0.5-to 1.0-p.m intervals in the cell membrane.
The cytoplasm lacks well-developed smooth or rough endoplasmic reticulum, in contrast to the other forms. All cytoplasmic areas show moderately dense concentrations of ribosomal particles.
Granular form. The granular form ( Fig. 3 and 5) can be seen in clinical samples or in cultures in which these cells may predominate as the culture matures. The granules are mitochondria, which are so numerous in the peripheral sphere of cytoplasm that, by DIC optics, the cell appears to be a solid ball of granules. Sections examined by electron microscopy, however, show that the large, relatively empty CB is still there, occupying the greater volume of the cell.
Granule cells are of average diameter (10 p.m). Giant cells have many mitochondria that are widely dispersed as rosettes surrounding single nuclei or clusters of nuclei. In contrast to the ameba form, in the granule form a distinct cell membrane is present. Other types of CB granules, unseen by light microscopy, are membrane bound and range from finely granular material to electron-lucent empty granules and moderately electron-dense oval to spherical granules. The CB is a reproductive organelle (85) and the granules described probably have a role in schizogony.
Rough and smooth endoplasmic reticulum ( membranes lying either as a rectangular or semicircular array (Fig. 3B) . Vesicular structures along the cell surface extend from the CB and appear to cause an evagination of a thinner segment of the cytoplasmic membrane toward the outside (Fig. 3D) . (72), after a freeze-etch electron microscopic (FEM) study, reported marked structural differences between the CB membrane and the outer or cytoplasmic membrane. Although B. hominis is a difficult organism to fix properly, remarkable agreement exists between FEM and TEM findings concerning cell shape, the nature of the CB, and the character of cell nucleus and organelles. The only additional information contributed by FEM to previously reported observations is the general completeness of membranes covering the CB granules and the difference in structure between inner and outer nuclear membranes. In addition, the three-dimensional views of all membrane surfaces permit a partial characterization of the tubular endosymbiont forms present in the cytoplasm and CB, observed initially by DIC microscopy (93) .
The freeze fracture technique cleaves lipid cell membranes down the middle presumably through the hydrophobic portions. Thus, any surfaces revealed by the fracture process are covered by lipid membranes. FEM The outer membrane has pores, approximately 50 nm in diameter, which are evenly distributed throughout the membrane surface. The inner or CB membrane has intramembranous particles and indentations. The indentations are distributed in a pattern similar to outer membrane pores. Outer and inner membranes may communicate directly by means of the pore indentation system. The nucleus is delimited by two membranes. The outer nuclear membrane contains intramembranous particles that are twice as numerous as those of the inner nuclear membrane. The individual features of the CB, cytoplasmic organelles, and general shape of B. hominis seen by TEM (73, 91, 94) are confirmed by FEM.
An ultrastructural comparison of 10 stock cultures by Dunn et al. (19) shows wide size range in the CB form and in the thickness and density of surface coats. The cell membrane beneath the surface coats has electron-dense pits. The mitochondria display a wide size range reflecting changes concomitant with division and metabolism. "Budding" or apparent phagocytosis of mitochondria into the CB via pockets in the CB membrane is reported, but passage into the CB has not yet been seen.
Unusual B. hominis Cells
A number of unidentified structures have been seen intermittently in a few strains of cultured B. hominis cells, e.g., a rod-shaped structure seen both by TEM and light microscopy (83a). By TEM, the rods are crystalline and have the electron lucency characteristic of protein. They are found intracellularly but are often not contained within a single cell (Fig. 6A to C) ; they may extend through up to three or four adjacent cells. The rods are up to 10 ,um wide and of highly variable length.
A "chestnut burr" cell may predominate in degenerating cultures (Fig. 6D) . The refractile spikes originate from the cell membrane and give the cell a brightly refractile golden appearance. The culture does not recover from this condition.
Old cultures synthesize excess lipid, which collects inside the cell as tiny globules. These coalesce and form larger globules until the cell is full of lipid (Fig. 6E) . The lipid globules apparently are not membrane enclosed and may stem from synthetic activity of the special anaerobic mitochondria.
Another cell type (Fig. 6F) Fig. 5A and B) are not identified with certainty but may be of mitochondrial origin. They are similar in size to mitochondria (dark bodies in Fig. 5A and B) but of ghostlike appearance, with irregular inclusions of varying electron density. The inclusions in some of the bodies appear to be degenerate cristae.
MITOCHONDRIA
Considerable research has been done on the B. hominis mitochondria because of the paradox of a cell with strict anaerobic metabolism containing hundreds of mitochondria as the most numerous organelle. They make up more of the cell's bulk than the sum of the other organelles. Purification by density gradient centrifugation has failed because of massive and tenacious mitochondrial aggregation on release from the cell, a common problem in mitochondrial research. Purification by differential centrifugation is adequate for determination of enzymes unique to mitochondria (88) . The B. hominis mitochondria are devoid of cytochromes. There is no activity of the mitochondrial enzymes pyruvate dehydrogenase complex, ketoglutarate dehydrogenase complex, isocitrate dehydrogenase, glutamate dehydrogenase, and cytochrome c oxidase (90) . Thus, the function of the anaerobic mitochondria in B. hominis remains unknown. Other enzymes absent from B. hominis are gammaglutamyl transpeptidase, alkaline phosphatase (a lysosomal marker), and creatine kinase isoenzymes (90) .
The basic ultrastructure of the B. hominis mitochondrion was shown by TEM to match that of an archetypical mitochondrion (90) . B. hoininis mitochondrial cristae are short, saccate or globular structures in the evidently resting organelle (Fig. 5C ), but within a few hours can elongate to long tubules as the mitochondrion itself elongates radially from the rosettes (Fig. 2D) . The cristae also elongate (Fig.  SD) , branch, and make abrupt right-angle bends. Evidence that the mitochondria are functional includes the following: (i) it is unlikely that a vestigial, useless organelle would be retained by the cell; (ii) they normally surround the nucleus as small spheres (0.2 to 0.5 ,um in diameter) and then elongate as tubular, sometimes branched, organelles up to 5 ,um in length and migrate from the cell nucleus as the cell ages; (iii) they stain brightly and specifically with Janus green or rhodamine 123, indicating that they have a typical, physiologically active outer membrane; (iv) their numbers per cell are not fixed but vary from two to four in B. hominis cells in the intestine and in rapidly dividing cells in vitro in late log growth phase (other than granule cells which have hundreds of them); (v) B. hominis synthesizes and stores lipid in quantities sufficient to displace most of the volume of the cytoplasm; there is a possibility that the mitochondria synthesize the lipid. This hypothesis is based partially on observations of cells in heated-stage culture chambers showing massive aggregations of thousands of mitochondria that escaped from ruptured cells. Rivulets of lipid stream from inside the mass and form droplets at the periphery which coalesce to form globules (89) . dodyogony. In the host, division is usually by binary fission (Fig. 2B) . The ameba form may reproduce by plasmotomy, i.e., the cutting off of one or more progeny from roughly circular extensions of the cell. These progeny contain one or more nuclei, but are without a CB.
The CB is the organelle in which schizogony occurs. Progeny may fill the parent cell, or schizont (Fig. 7A) , until the cell bursts, releasing them to the environment (Fig. 7B) . Numbers of progeny range from one to hundreds, the organisms diminishing inversely in size as numbers increase. Progeny of widely varying size and development may occupy the same schizont (Fig. 7C) . Endodyogony is less common and produces two large progeny with the CB (Fig.  7D) .
Viable progeny from schizonts appear as tiny B. hominis cells, somewhat dark, condensed, and nonrefractile (Fig.  7B) . A possibility remains that these viable granules, or progeny, are more resistant to air exposure, drying, and less than optimal temperature, but this has not been tested. These brown condensed B. hominis cells have not been studied by TEM. Sexual reproduction has not been described in B. hominis.
Generation time for the CB form in culture is 8.5 to 19.4 h, depending on the strain studied, the average being 11.7 h (92). Only about 5% of the cells in log-phase culture are in division, but the generation time formula considers every cell to be in division. Division times of individually observed cells just initiating division are much less, 40 to 60 min (92).
DIAGNOSIS Slide Preparation
Wet mounts and trichrome-stained smears are recommended for stool examination. This laboratory has successfully used the FPC ova and parasite concentration device (Evergreen Scientific, Los Angeles, Calif.) for many years. Trophozoites of B. hominis remain intact after concentration for examination by wet mount or stained slide preparations. Representative morphology of trichrome-stained cells is seen in Fig. 8 (89a) .
Preservation by Freezing
Preservation by lyophilization has not been successful in our laboratory trials; however, B. hominis culture sediments may be frozen successfully. The sediment from 3-day-old cultures is treated by submerging a 1-ml pipette tip through the overlay to the sediment at the base of the slant and releasing 0.1 ml of glycerol. In the same manner, 0.1 ml of dimethyl sulfoxide is added. The overlay is covered with 3 ml of sterile mineral oil and the culture is immediately frozen slowly to -70°C. To slow the rate of freezing, the tubes are first wrapped in a few layers of tissue paper and enclosed in a cardboard mailing tube. In this state, the cells are viable for at least 2 years. B. hominis ATCC 50177 is available as a frozen culture from the American Type Culture Collection, Rockville, Md.
SURVEYS OF INTESTINAL PARASITES INCLUDING B. HOMINIS
Although the question has been raised as to whether B. hominis is an intestinal pathogen, during the early 20th century, most articles that described diarrheal disease caused by protozoans included B. hominis without distinction. In 1916, Fantham (20) (59) . Also in 1988, Taylor et al. (74) , in a survey of bacterial and protozoan enteropathogens in Nepal, reported B. hominis in 33% of 328 expatriate patients, confirming the high incidence of this parasite reported previously in Kathmandu (2) . By comparison, enterotoxigenic Escherichia coli was found in 24% of patients; Shigella sp., in 14%; G. lamblia, in 12%; Campylobacter sp., in 9%, and rotavirus, in 8% (74) . These values demonstrate a high rate of pathogen acquisition among travelers to Nepal. Nguyen (39) , who referred to B. hominis infection as "an infection that is difficult to get rid of," treated patients with emetine. In 1917, Lynch provided two reports of B. hominis infections. One of these (42) related B. hominis to ulcers lining the "pellagrous intestine." He noted that B. hominis morphology within the ulcers was strikingly different from that of organisms in the lumen of the intestine. This observation correlates with recent studies showing that the ameba form is more common than the CB form in the intestinal mucosa. Lynch's second paper was the previously cited report of B. hominis infections in pellagra patients in South Carolina (41) . In a third paper (43), he described a study with human serum as culture medium either undiluted or diluted in saline. He asserted that Alexieff (1) hominis. Sangiorgi (64) described the "critical" picture of B. hominis infection as the presence of numerous "blastocysts" in the "most florid period of their life," with abnormal numbers of leukocytes, erythrocytes, and epithelial cells and mucus. The "postcritical" period saw regression of these elements and change in B. hominis morphology to "constrained elements, primarily distributed in dense groups. Are these elements equivalent to spores?" These elements were probably progeny resulting from schizogony. Sangiorgi studied 2,000 Italian soldiers in Albania in 1918 (63) and in 1933 (65) reported on an outbreak among 100 Italian soldiers in Albania who were infected with B. hominis alone. From Italy, Milella, in 1936, reported on 116 cases of diarrhea caused by B. hominis (50) . In 1937, Calderin (9) affirmed the entity of blastocystosis in Italy.
In 1972, Wolynska and Soroczan (80) examined 312 Polish peasant women for vaginal parasites. They reported B. hominis with "various grades of invasion" in 47 women (11.5%), Trichomonas vaginalis in 19 (6.0%), Enterobius vermicularis in 27 (8.6%), and "Monilia" in 11 (3.4%). In 16 cases, B. hominis was found in the rectal area, in 22 cases in the vagina only, and in 9 cases in both rectal and vaginal areas. The women had colpitis and cervical erosion. The authors attributed the disease to poor personal hygiene.
One well-studied case of blastocystosis reported in 1976 (94) involved a 45-year-old alcoholic male who developed a fulminant refractory diarrhea. He produced from 5 to 20 liters of diarrheal fluid daily and required continuous administration of large volumes of intravenous fluids. B. hominis counts (performed in Neubauer hemacytometer chambers) rose to and remained at an average of 8.3 x 106/ml in the diarrheal fluid. The patient died of aspiration pneumonia after 3 months. Before his death, treatment for 7 days with metronidazole (250 mg, three times daily) reduced B. hominis numbers by one-third and caused the appearance of injured protozoan cells. In retrospect, considering the elimination time and dilution in the fluid volume, the dose and treatment span were inadequate. Intensive search by medical personnel disclosed no underlying disease or other etiologic agent of this fatal case. During infection, the mixed presence of CB and ameba forms gave way to the ameba form only. Identification of the agent as B. hominis was done by wet mount morphology under DIC optics, by TEM, and by indirect fluorescent-antibody staining. TEM verification depended particularly on finding typical crescentic nuclear chromatin and mitochondria. No CB were present.
An epizootic with animal deaths was reported in 1980 (48) in a primate colony. Cases have been described in human and nonhuman primates in a zoo. In 1983, May et al. (46) reported that 52% of 180 male homosexuals in south Florida had B. hominis, whereas 16% of 45 Sheehan et al. (66) reported an "association of Blastocystis hominis with signs and symptoms of human disease" and Jarecki-Black et al. (30) reported a case of blastocystosis in a 2-year-old child. In 1987, Kain et al. (32) reported a definitive retrospective study of 1,496 patients over a 3-year period, of whom 190 (12.7%) carried B. hominis. Ten characteristics were used to characterize the patients and their disease: (i) duration of symptoms either acute (<2 weeks) or chronic (>2 weeks) before seeking medical attention; (ii) history of underlying gastrointestinal disease or immune deficiency that might produce gastrointestinal symptoms; (iii) recent medications that might affect gastrointestinal function; (iv) travel history to the tropics or consumption of untreated water in rural or wilderness areas of North America within 6 months of initial stool examination; (v) symptom complex including diarrhea, abdominal pain, nausea and vomiting, arthralgia, or arthritis; (vi) concomitant infection with other potentially pathogenic bowel parasite or bacteria; (vii) leukocytosis (>11,000 leukocytes per ,ul) and eosinophilia (>450 eosinophils per ,ul); (viii) endoscopic, histologic, and radiologic observations; (ix) clinical response by return to an asymptomatic state or distinct improvement in gastrointestinal signs or symptoms on follow-up examination; and (x) microbiologic response by clearance or decrease of B. hominis numbers.
Of 100 patients infected with B. (51) provided a review and another negative report about the pathogenesis of B. hominis. However, all 11 of their patients were compromised by other underlying gastrointestinal disease.
Most of the early studies were done in geographic areas with a high level of endemic blastocystosis and crowded living conditions, areas that also experience fulminant epidemics of blastocystosis. North America is not a good geographic area in which to study B. hominis disease. The current incidence in the United States is ca. 4 to 12%, down from the 18% reported in the 1960s, whereas the incidence reported from tropical countries ranges from 20 to 50% (34) . As might be expected, the incidence of B. hominis in hospital as well as community populations varies widely. The incidence in the National Institutes of Health Clinical Center was reported as 18% in 1983 but has declined to ca. 6% in 1989. Other laboratories have reported 11.6% incidence (45), 35.5% incidence among, 2,391 troops returning from duty in a tropical country (34) , and 16% (14) . B. hominis was found in 93 (52%) of 180 homosexual men in south Florida (46) . In the same study, only 8 (17%) of 47 heterosexual women and 7(16%) of 45 heterosexual men had B. hominis. The reduced incidence in the United States in the past two decades apparently reflects epidemiologic factors. Many reports of infections now originating from North America include immigrants from countries (usually tropical) known to have a high incidence of gastrointestinal and other disease, but there are not enough of these patients to affect the overall incidence of blastocystosis. Much remains to be learned about the epidemiology of B. hominis infections and transmission, but overcrowding, malnutrition, and poor hygiene must be important factors. The fecal-oral route, including contaminated food and water, appears to be a factor. oped diarrhea of >1-week duration. After intracecal inoculations, 13 of 28 animals developed infections. Gross cecal hyperemia was observed in those animals with heavy infections. Microscopic examination revealed frequent penetration by B. hominis cells of the epithelium (Fig. 4C) but not the lamina propria, where a slight increase in cellularity was noted. Infections did not result from inoculation of axenic strains alone, and only one of eight guinea pigs developed an infection after inoculation with a monozenic culture that included Proteus vulgaris.
EFFECT OF DISEASE ON LARGE
Fractions of axenic B. hominis cultures were injected into isolated segments of rabbit ileum (ileal loops) (83a). The fractions tested were heated and unheated whole cultures, culture filtrate, and column-purified filtrate fractions. After 24 h, the segments were excised (Fig. 4D ) and the fluid volume was measured in the test and control segments. The ratio of test segment fluid volume to that in the control segment was used to measure the presence of a diarrheagenic toxin. Unheated whole culture, culture filtrate, and some purified protein fractions were positive, with high ratios of test loop to control loop fluid volumes, suggesting the presence of a diarrheagenic toxin.
Effects in Humans
Inflammation of the intestine in blastocystosis has been described by Shikiya (26%) of 50 patients with B. hominis infections showed abnormalities at endoscopy and 17 (34%) of 50 showed abnormalities on histological examination. However, none of 14 patients in whom other possible causes of gastroenteritis were absent showed abnormalities on endoscopy, and on biopsy, only 1 of 13 showed mild acute inflammation in the lamina propria. That patient had high numbers of B. hominis but no invasive disease was present.
The most usual complaint of blastocystosis patients is of intense abdominal discomfort accompanied by pain. Diarrhea is not standard, and constipation is common. The symptoms gleaned from the literature include abdominal pain, discomfort, anorexia, bloating, cramps, diarrhea, constipation, alternating diarrhea and constipation, watery diarrhea, mucus diarrhea, vomiting, dehydration, sleeplessness, nausea, weight loss, inability to work, lassitude, dizziness, flatus, pruritis, and tenesmus. Blood in the stool as well as excessive mucus and leukocytes have been reported. Moderate to severe eosinophilia is not uncommon and was reported in 8 of 19 patients in one study (66) . TREATMENT Early treatment for B. hominis infections was the same as for E. histolytica. Purging with salts followed by an enema was considered the standard treatment. Large doses of dilute hydrochloric acid by mouth were prescribed and one or more of several arsenilic acid derivatives, such as Stovarsol, Narsenol, and, later, Carbarsone (4, 10, 15, 39, 46, 53, 54, 62, 64, 67, 76, 81, 82) . The arsenicals resulted in permanent clearance of B. hominis from the entire gastrointestinal tract, for in the early literature, B. hominis was often reported in the jejunum and duodenum as well as the cecum and colon.
Diiodohydroxyquinoline, iodochlorhydroxyquinoline (Entero-vioform), and emetine have been used, the last extensively by the British (39, 77) . Emetine is still available but needs further evaluation (79) . In our experience, Enterovioform was notably successful for permanent clearance of B. hominis, but this drug has now been banned in the United States following an adverse report in a Japanese study (29) . After World War II, physicians in Japan prescribed the drug freely for a variety of ailments, usually at doses of 1 g per day for indefinite periods. Thousands of patients developed neurologic disease but almost all returned to normal when they stopped using the drug. Entero-vioform undoubtedly was misused; therefore, the ban seems premature. If diiodohydroxyquinoline had been used in the same way, similar problems might have been encountered.
In vitro tests (86) of 10 antiprotozoal drugs found 6 to be effective against B. hominis. In order of effectiveness, they are emetine, metronidazole, furazolidone, trimethoprimsulfamethoxazole, 5-chloro-8-hydroxy-7-iodoquinoline (Entero-vioform), and pentamidine. Moderately effective were two other quinolines, chloroquine and 5,7-diiodo-8-hydroxyquinoline (Floraquin). Diloxanide furoate was not inhibitory nor were paromomycin and other antimicrobial agents. These in vitro results have been confirmed in patients, except that trials of pentamidine and diloxanide furoate have not yet been reported.
Through anecdotal reports, it has become evident that there are a significant number of treatment failures with metronidazole and trimethoprim-sulfamethoxazole. When adult patients can tolerate metronidazole (essentially the drug of choice), the dose is increased from 250 to 750 mg three times daily. More primary cures are achieved with the higher dosages administered for 10 days and recurrences of the parasite are prevented. Intolerance to the elevated dosage is a common problem, however. Some patients do not respond to treatment and suffer a painful and debilitating chronic infection. Additionally, more effective drugs are needed. Trimethoprim-sulfamethoxazole has been used to stop an outbreak of blastocystosis among primates at the San Diego zoo; however, insufficient data are available to assess its efficacy in humans.
Many individuals suffer from chronic blastocystosis, infections refractory to metronidazole and other drugs. Dehydroemetine is available as an alternative. It has been used for treating amebic dysentery and amebic abscesses when metronidazole fails. Tetracycline could be coadministered when treating blastocystosis to remove bacterial support essential to B. hominis survival (79) . Complete information about precautions, adverse effects, dosage, and intramuscular administration of dehydroemetine should be obtained, and the drug should always be used in a hospital setting.
With the growing problem of resistant infections, another look might be given at the arsenilic acid derivatives reported to be effective in the early literature. Thus far, in vitro tests have not been done on members of this group. Carbarsone is available in the United States, and judging from the success reported in older studies, a retrial might be in order. Treatment information for parasitic disease (81) Reproduction is asexual, usually by binary fission. Shizogony occurs in cultured cells. The CB appears to be an organelle whose specific purpose is for reproduction by shizogony. From 2 to 30 progeny are derived from schizogony. The ameba form reproduces by plasmotomy; it has no CB.
The pathology of B. hominis infections has been studied in gnotobiotic guinea pigs in which inflammation of the intestinal mucosa and invasion of the superficial layers were seen.
Only limited studies of human pathology are available.
Those who have studied mucosal histopathology report inflammation and cellular changes that resolve after treatment. More study in this area is strongly indicated (32, 44, 57, 62, 67, 75) .
Ultrastructural details of B. hominis major forms, except for the schizont, are complete. The organism has no cell wall. The concentric CB takes up as much as 95% of the cell. The major organelles, which include multiple nuclei, Golgi apparatus, mitochondria, endoplasmic reticulum, fat, and other inclusions, are confined in two or four opposed pods in a thin band of peripheral cytoplasm between the spherical entire plasma membrane and the CB membrane. The pods buldge the CB membrane inward. There is evidence of a bacteroid endosymbiont.
Education about B. hominis is needed. Entry of recent findings into new textbooks is imperative for its understanding among medical practitioners. Laboratory workers need to be aware of it for many reasons. The College of American Pathologists includes B. hominis in its proficiency testing samples and requires that it be reported from clinical sam- ples.
